Corcept Therapeutics EPS Diluted from Accounting Change (Quarterly) Analysis

Corcept Therapeutics, Inc. (CORT)

34.82 +0.58 (+1.69%) USD | NASDAQ | Feb 20, 16:00

34.60 -0.22 (-0.63%) After-Hours: 20:00

View EPS Diluted from Accounting Change (Quarterly) for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Axsome Therapeutics, Inc.	--
United Therapeutics Corp.	--
Harrow, Inc.	--
Ultragenyx Pharmaceutical, Inc.	--
Amneal Pharmaceuticals, Inc.	--